- Home
- GDV vs OGN Comparison
GDV vs OGN Comparison
Compare GDV & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDV
- OGN
- Stock Information
- Founded
- GDV 2003
- OGN 1923
- Country
- GDV United States
- OGN United States
- Employees
- GDV N/A
- OGN N/A
- Industry
- GDV Investment Managers
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- GDV Finance
- OGN Health Care
- Exchange
- GDV Nasdaq
- OGN Nasdaq
- Market Cap
- GDV 2.2B
- OGN 2.5B
- IPO Year
- GDV N/A
- OGN N/A
- Fundamental
- Price
- GDV $26.26
- OGN $9.99
- Analyst Decision
- GDV
- OGN Hold
- Analyst Count
- GDV 0
- OGN 4
- Target Price
- GDV N/A
- OGN $18.00
- AVG Volume (30 Days)
- GDV 186.0K
- OGN 3.9M
- Earning Date
- GDV 01-01-0001
- OGN 08-05-2025
- Dividend Yield
- GDV 5.81%
- OGN 0.80%
- EPS Growth
- GDV N/A
- OGN N/A
- EPS
- GDV N/A
- OGN 2.88
- Revenue
- GDV N/A
- OGN $6,294,000,000.00
- Revenue This Year
- GDV N/A
- OGN N/A
- Revenue Next Year
- GDV N/A
- OGN $1.11
- P/E Ratio
- GDV N/A
- OGN $3.49
- Revenue Growth
- GDV N/A
- OGN N/A
- 52 Week Low
- GDV $18.04
- OGN $8.01
- 52 Week High
- GDV $23.00
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- GDV 74.91
- OGN 52.90
- Support Level
- GDV $24.57
- OGN $9.55
- Resistance Level
- GDV $25.29
- OGN $10.44
- Average True Range (ATR)
- GDV 0.28
- OGN 0.36
- MACD
- GDV 0.09
- OGN 0.03
- Stochastic Oscillator
- GDV 97.24
- OGN 54.04
About GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.